Calidi Biotherapeutics
@CalidiBio
Followers
208
Following
10
Media
21
Statuses
55
Calidi Biotherapeutics is a clinical-stage biopharmaceutical company revolutionizing oncolytic viral therapies with stem cell-based platforms
San Diego, California
Joined June 2022
📣 We are excited to announce that CEO, Dr. Eric Poma, will be presenting at the H.C. Wainwright 27th Annual Global Investment Conference, taking place September 8–10, 2025 at the Lotte New York Palace Hotel in NYC. Read more here: https://t.co/DgsnNNCSWZ
#calidi #redtail $CLDI
0
2
4
We are thrilled to announce that CLD‑201 (SuperNova), our allogeneic adipose stem-cell loaded oncolytic virus, has received FDA Fast Track designation for the treatment of patients with soft tissue sarcoma. Read more here: https://t.co/0Hvew1jfQS
#CLD201 #calidi #FastTrack
calidibio.com
Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma. SAN DIEGO,...
5
5
15
We are excited to announce a shareholder letter from CEO, Eric Poma, PhD, highlighting changes in Calidi's leadership, its focus and priorities, and in its balance sheet and operating expenses. Read more here: https://t.co/oEff9avOsH
#calidi #redtail #virotherapy $CLDI
calidibio.com
Calidi Biotherapeutics Announces Shareholder Letter from CEO SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology...
1
4
10
Calidi Biotherapeutics CEO, Eric Poma, represented the company at the BIO conference in Boston last week! Dr. Poma had a series of productive meetings that highlighted Calidi’s innovative approach and deep commitment to advancing immuno-oncology. #calidi #virotherapy #BIO $CLDI
2
3
12
@CalidiBio today announced the presentation of its lead RedTail platform candidate, CLD-401, at the American Society of Clinical Oncology @ASCO Annual Meeting. Read more here: https://t.co/KYxBPNvd5a
#calidi #redtail #systemic #asco $CLDI
4
2
10
đź“Ł Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights Read more to learn about Calidi's recent corporate developments: https://t.co/yrQlRAbwHq
#calidi #redtail #virotherapy $CLDI
ir.calidibio.com
Bolstered management team with hires of Chief Executive Officer and Chief Medical Officer with deep biopharmaceutical experience Announced selection of IL15-superagonist as first payload to be...
0
2
3
@CalidiBio today announced the succession of its CEO, Allan Camaisa, to Eric Poma, Ph.D., who was appointed as CEO and member of the Board of Directors of Calidi. Mr. Camaisa will continue to serve as a member of the Board. Read more here:
0
1
3
We are thrilled to announce the appointment of Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor. Read more here:
0
0
4
@CalidiBio is pleased to report fourth quarter and full-year 2024 financial results and recent operational highlights. These include: Read more about these exciting updates here:
0
0
4
🧠Calidi Biotherapeutics $CLDI Advances Virotherapy for Aggressive Brain Cancer @CalidiBio, in partnership with @CityofHope, shared promising progress from its Phase 1 trial of CLD-101, a novel stem cell-based virotherapy for recurrent high-grade glioma—one of the deadliest
1
3
10
@CalidiBio and @cityofhope have jointly announced progress from a Phase 1 clinical trial using Calidi's CLD-101, a neural stem cell-based oncolytic virotherapy aimed at treating recurrent high-grade glioma. Read more here:
ir.calidibio.com
SAN DIEGO and LOS ANGELES, March 26, 2025 (GLOBE NEWSWIRE) - Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of...
0
3
3
📢 Missed the @CalidiBio Investor Webinar? Watch the Replay Now! 🚀 On Wednesday, $CLDI shared key updates on its groundbreaking oncolytic virotherapies, financial strength, and upcoming milestones. 🔎 Key Takeaways: ✅ Advancing glioblastoma & solid tumor treatments with stem
0
3
22
@CalidiBio is thrilled to announce the presentation of new data of our systemic virotherapy RTNova Platform at the @AACR Annual Meeting in April 2025. Read more here:
1
1
2
@CalidiBio recognizes @WendyPizarroEsq as a speaker today, October 21, 2024, at the San Diego Precision in Clinical Trials Summit in San Diego, CA. She will be speaking on Diversity, Equity and Inclusion Strategies in Clinical Trials and Patient Recruitment.
1
1
2
Yesterday, we at @CalidiBio hosted an exciting virtual presentation diving deep into the groundbreaking science and innovative technology we’re developing to combat cancer. If you missed it, don’t worry! Watch the Replay Here:
0
0
3
Join Us for an Exciting Webinar: Calidi’s Groundbreaking Cancer Treatment 📅 Date: September 11th 🕓 Time: 4:15 PM ET 🔗 Register now: https://t.co/yKM3E7bXzy
#calidi #virotherapy $CLDI
redchip.zoom.us
Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. Calidi’s novel stem cell-based platforms are utiliz...
0
0
2
@CalidiBio was recently featured in an article by Fred Grier with @SDbusiness, highlighting the launch of our new subsidiary, Nova Cell. Read more here: https://t.co/aNBcoy0ZO3
#calidi #novacell #stemcells #biotech #sandiego $CLDI
sdbj.com
LA JOLLA – Calidi Biotherapeutics, a UTC-based biotech company specializing in developing cell-based therapies, has secured fresh capital and spin off a new c
0
0
1
đź“Ł Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results. Read more: https://t.co/9vqEwKEn3x
#calidi #virotherapy #stemcells #biotech $CLDI
globenewswire.com
Launched Nova Cell subsidiary with $2 million investment from Dr. Ronald Rigor to advance Calidi’s Adult Adipose Allogeneic (AAA) stem cell innovative...
0
1
2
@CalidiBio is proud to announce the launch of our new subsidiary, Nova Cell, and a $3 million aggregate investment from Dr. Ronald Rigor. Read more below: https://t.co/8ZCMvMvJaX
#stemcell #calidi #NovaCell $CLDI
globenewswire.com
SAN DIEGO, July 29, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company...
0
1
1
@CalidiBio recently announced the issuance of a new U.S. patent covering our novel SuperNova technology! Read more below:
globenewswire.com
SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company...
0
1
2